Minghui Duan

19PUBLICATIONS
43CO-AUTHORS
Molecular targetsGene and molecular therapyPredictive and prognostic markersMedical infection agents (incl. prions)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 29, 2026
Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy.

|Oct 31, 2025
Long-term efficacy and safety of ropeginterferon alfa-2b under its HIDAT regimen for the treatment of polycythemia vera.

Shanshan Suo, Rongfeng Fu, Albert Qin

|Jul 03, 2025
Incidence, Outcomes and Risk Factors for Atrial Fibrillation in Patients With JAK2V617F-Positive Myeloproliferative Neoplasms.

Guangshuai Teng, Ke Shang, Yuhui Zhang

|Dec 11, 2024
Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology.

Rong Wang, Zhongxun Shi, Yuan Zhang

|Nov 08, 2024
BRAF Deletion in Adult Patients with Langerhans Cell Histiocytosis Correlates with Multisystem Disease and Poor Outcomes.

Min Lang, Long Chang, Hao Cai

|Oct 27, 2024
Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa-2b.

Shanshan Suo, Rong Feng Fu, Albert Qin

Pageof 4

Frequent Collaborators

11 joint publications

Jian Li

9 joint publications

Xin-Xin Cao

7 joint publications

Dao-Bin Zhou

5 joint publications

Lu Zhang